Systemic short chain fatty acids limit antitumor effect of CTLA-4 blockade in hosts with cancer - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Nature Communications Année : 2020

Systemic short chain fatty acids limit antitumor effect of CTLA-4 blockade in hosts with cancer

Résumé

Gut microbiota composition influences the clinical benefit of immune checkpoints in patients with advanced cancer but mechanisms underlying this relationship remain unclear. Molecular mechanism whereby gut microbiota influences immune responses is mainly assigned to gut microbial metabolites. Short-chain fatty acids (SCFA) are produced in large amounts in the colon through bacterial fermentation of dietary fiber. We evaluate in mice and in patients treated with anti-CTLA-4 blocking mAbs whether SCFA levels is related to clinical outcome. High blood butyrate and propionate levels are associated with resistance to CTLA-4 blockade and higher proportion of Treg cells. In mice, butyrate restrains anti-CTLA-4-induced up-regulation of CD80/CD86 on dendritic cells and ICOS on T cells, accumulation of tumor-specific T cells and memory T cells. In patients, high blood butyrate levels moderate ipilimumab-induced accumulation of memory and ICOS + CD4 + T cells and IL-2 impregnation. Altogether, these results suggest that SCFA limits anti-CTLA-4 activity.
Fichier principal
Vignette du fichier
41467_2020_Article_16079.pdf (2.14 Mo) Télécharger le fichier
Origine : Fichiers éditeurs autorisés sur une archive ouverte
Licence : CC BY - Paternité

Dates et versions

hal-03109210 , version 1 (07-06-2023)

Identifiants

Citer

Clélia Coutzac, Jean Mehdi Jouniaux, Angelo Paci, Julien Schmidt, Domenico Mallardo, et al.. Systemic short chain fatty acids limit antitumor effect of CTLA-4 blockade in hosts with cancer. Nature Communications, 2020, 11 (1), ⟨10.1038/s41467-020-16079-x⟩. ⟨hal-03109210⟩
120 Consultations
25 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More